Abstract
We examined the effects of three cardiac glycosides, ouabain, digoxin and proscillaridin A, on the proliferation of estrogen independent MDA-MB-231 breast cancer cells. In terms of reduction in cell viability, the compounds rank for both 24 h and 48 h of incubation in MDA-MB-231 cells in the order proscillaridin A > digoxin > ouabain. Digoxin for 24 h and 48 h of incubation in MDA-MB-231 cells proved to be only slightly more potent than ouabain, with IC50 values of 122 ± 2 and 70 ± 2 nM, respectively, compared to 150 ± 2 and 90 ± 2 nM for ouabain. In contrast, proscillaridin A, was much more active and showed a high level of cytotoxic potency, IC50 51 ± 2 and 15 ± 2 nM for 24 h and 48 h of incubation, respectively. The concentrations of digoxin, ouabain and proscillaridin A needed to inhibit [3H]thymidine incorporation into DNA by 50% (IC50) in MDA-MB-231 cells for 24 h of incubation were found to be 124 ± 2 nM, 142 ± 2 nM, and 48 ± 2 nM, respectively. In the present study, we demonstrated that ouabain, digoxin, and proscillaridin A induce apoptosis in MDA-MB-231 cells by increasing free calcium concentration and by activating caspase-3.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Akimova, O. A., Bagrov, A. Y, Lopina, O. D., Kamernitsky, A. V., Tremblay, J., Hamet, P., and Orlov, S. N., Cardiotonic steroids differentially affect intracellular Na+ and [Na+]/[K+]i- independent signaling in C7-MDCK cells.J. Biol. Chem., 280, 832–839 (2005).
Bielawski, K., Winnicka, K., and Bielawska, A., Inhibition of DNA topoisomerases I and II, and growth inhibition of breast cancer MCF-7 cells by ouabain, digoxin and proscillaridin A.Biol. Pharm. Bull., 29, 1493–1497 (2006).
Blaustein, M. P., Physiological effects of endogenous ouabain: control of intracellular Ca2+ stores and cell responsiveness.Am. J. Physiol., 264, C1367-C1387 (1993).
Carmichael, J., Degraff, W., Gazdar, A., Minna, J., and Mitchell, J., Evaluation of a tetrazolinium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.Cancer Res., 47, 936–942 (1987).
Chen, J. Q., Contreras, R. G., Wang, R., Fernandez, S. V, Shoshani, L, Russo, I. H., Cereijido, M., and Russo, J., Sodium/potassium ATPase (Na+, K+-ATPase) and ouabain/ related cardiac glycosides: a new paradigm for development of anti-breast cancer drugs?Breast Cancer Res. Treat., 96, 1–15 (2006).
Cronauer, M. V., Hittmair, A., Eder, I. E., Hobisch, A., Culig, Z., Ramoner, R., Zhang, J., Bartsch, G., Reissigl, A., Radmayr, C., Thurnher, M., and Klocker, H., Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostate.Prostate, 31, 223- 233 (1997).
Duke, R. C. and Cohen, J. J., Morphological and biochemical assays of apoptosis.Curr. Protoc. Immunol., 17, 1–16 (1992).
Evans, W. Ch., Trease and Evan’s Pharmacognosy. London: WB Saunders, pp. 309–316 (1996).
Eymin, B., Dubrez, L, Allouche, M., and Solary, E., Increased gadd153 messenger RNA level is associated with apoptosis in human leukemic cells treated with etoposide.Cancer Res., 57, 686–695 (1997).
Florkiewicz, R. Z., Anchin, A., and Baird, A., The inhibition of fibroblast growth factor-2 export by cardenolides implies a novel function for the catalytic subunit of Na+, K+-ATPase.J. Biol. Chem., 273, 544–551 (1998).
Furuya, Y, Lundmo, P., Short, A. D., Gill, D. L., and Isaacs, J. T., The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin.Cancer Res., 54, 6167- 6175 (1994).
Grynkiewicz, G, Poenie; M., and Tsien, R. Y., A new generation of Ca2+ indicators with greatly improved fluorescence properties.J. Biol. Chem., 260, 3440–3450 (1985).
Hashimoto, S., Jing, Y, Kawazoe, N., Masuda, Y., Nakajo, S., Yoshida, T., Kuroiwa, Y., and Nakaya, K., Bufalin reduces the level of topoisomerase II in human leukemia cells and affects the cytotoxicity of anticancer drugs.Leukemia Res., 21, 875- 883(1997).
Hauptman, P. J., Garg, R., and Kelly, R. A., Cardiac glycosides in the next millennium.Prog. Cardiovasc. Dis., 41, 247–254 (1999).
Haux, J., Lam, M., Marthinsen, A. B. L., Strickert, T., and Lundgren, S., Digitoxin, in non toxic concentrations, induces apoptotic cell death in Jurkat T cells in vitro.J. Oncol., 31, 14- 20 (1999).
Huang, Y T., Chueh, S. C, Teng, C. M., and Guh, J. H., Investigation of ouabain-induced anticancer effect in human androgen-independent prostate cancer PC-3 cells.Bioch. Pharmacol., 67, 727–733 (2004).
Johansson, S., Lindholm, P., Gullbo, J., Larsson, R., Bohlin, L., and Claeson, P., Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells.Anticancer Drugs, 12, 475- 483 (2001).
Laemmli, U. K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4.Nature (London), 227, 680–685 (1970).
Lopez-Lazaro, M., de la Pena, N. P., Pastor, N., Martin-Cordero, C., Navarro, E., Cortes, F., Ayuso, M. J., and Toro, M. V., Anti-tumor activity of Digitalis purpurea subsp. heywoodii.Planta Med., 69, 701–704 (2003).
Lopez-Lazaro, M., Pastor, N., Azrak, S. S., Ayuso, M. J., Austin, C. A., and Cortes, F., Digitoxin inhibits the growth of cancer cell lines at concentrations commonly found in cardiac patients.J. Nat. Prod., 68, 1642–1645 (2005).
Manna, S. K., Sah, N. K., Newman, R. A., Cisneros, A., and Aggarwal, B. B., Oleandrin suppresses activation of nuclear transcription factor-kB, activator protein-1, and c-Jun NH2- terminal kinase.Cancer Res., 60, 3838–3847 (2000).
Marklund, L, Behnam-Motlagh, P., Henriksson, R., and Grankvist, K., Bumetanide annihilation of amphotericin B-induced apoptosis and cytotoxicity is due to its effect on cellular K+ flux.J. Antimicrob. Chemother., 48, 781–786 (2001).
Martin, S. J., Reutelingsperger, C. P. M., McGahon, A. J., Rader, J. A., and van Schie, R. C., Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of bcl-2 and abl.J. Exp. Med, 182, 1545- 1556 (1995).
Masuda, Y., Kawazoe, N., Nakajo, S., Yoshida, T., Kuroiwa, Y., and Nakaya, K., Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells.Leukemia Res., 19, 549–556 (1995).
McConkey, D. J., Lin, Y., Nutt, L. K., Ozel, H. Z., and Newman, R. A., Cardiac glycosides stimulate Ca2+ increases and apoptosis in androgen-independent, metastatic human prostate adenocarcinoma cells.Cancer Res., 60, 3807–3812 (2000).
Oh, J. and Lee, K., Possible implication for an indirect interaction between basic fibroblast growth factor and Na+, K+-ATPase.Arch. Pharm. Res., 21, 707–711 (1998).
Sen, C. K., Sashwati, R., and Packer, L., Fas mediated apoptosis of human jurkat T-cells: intracellular events and potentiation by redox-active alpha-lipoic acid.Cell Death Differ, 6, 481- 491 (1999).
Smith, J. A., Madden, T., Vijjeswarapu, M., and Newman, R. A., Inhibition of export of fibroblast growth factor-2 (FGF-2) from the prostate cancer cell lines PC3 and DU 145 by Anvirzel and its cardiac glycoside component, oleandrin.Bioch. Pharmacol., 62, 469–472 (2001).
Stenkvist, B., Bengtsson, E., Eklund, G, Eriksson, O., Holmquist, J., Nordin, B., and Westman-Naeser, S., Evidence of a modifying influence of heart glucosides on the development of breast cancer.Anal. Quant. Cytol., 2, 49-54 (1980).
Stenkvist, B., Bengtsson, E., Dahlqvist, B., Eriksson, O., Teppo, L., and Idalan-Heikkila, J., Cardiac glycosides and breast cancer, revisited.N. Engl. J. Med., 306, 484 (1982).
Stenkvist, B., Is digitalis a therapy for breast carcinoma?Oncol. Rep., 6, 493–496 (1999).
Vermes, I., Haanen, C., Steffens-Nakken, H., and Reutelingsperger, C., A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V.J. Immunol. Methods, 184, 39–51 (1995).
Villa, P., Kaufmann, S. H., and Earnshaw, W. C., Caspases and caspase inhibitors.Trends Biol. Sci., 22, 388–393 (1997).
Wade, O. L., Digoxin 1785–1985. Two hundred years of digitalis.J. Clin. Hosp. Pharm., 11, 3–9 (1986).
Wang, C. Y, Mayo, M. W., and Baldwin, A. S., Jr., TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kB.Science, 274, 787–789 (1996).
Watabe, M., Masuda, Y., Nakajo, S., Yoshida, T., Kuroiwa, Y., and Nakaya, K., The cooperative interaction of two different signaling pathways in response to bufalin induces apoptosis in human leukemia U937 cells.J. Biol. Chem., 271, 14067- 14073(1996).
Winnicka, K., Bielawski, K., and Bielawska, A., Cardiac glycosides in cancer research and cancer therapy.Acta Polon. Pharm., 2,109–115 (2006).
Yeh, J. Y, Huang, W. J., Kan, S. F., and Wang, P. S., Inhibitory effects of digitalis on the proliferation of androgen dependent and independent prostate cancer cells.J. Urology, 166, 1937–1942 (2001).
Yeh, J. Y, Huang, W. J., Kann, S. F., and Wang, P. S., Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells.Prostate, 54, 112–124 (2003).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Winnicka, K., Bielawski, K., Bielawska, A. et al. Apoptosis-mediated cytotoxicity of ouabain, digoxin and proscillaridin A in the estrogen independent MDA-MB-231 breast cancer cells. Arch. Pharm. Res. 30, 1216–1224 (2007). https://doi.org/10.1007/BF02980262
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02980262